Malonate-assisted purification of human caspases

Protein Expression and Purification

Volumn 41, Issue 1, 2005, Pages 148-153

  Scheer, Justin M ^a   Wells, James A ^a   Romanowski, Michael J ^a  

^a Sunesis Pharmaceuticals Inc   (United States)

Author keywords

Caspase; Malonate; Purification; Refolding

Indexed keywords

EID: 15744387616     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2005.01.008     Document Type: Article

References (26)

1. S.J. Riedl, and Y. Shi Molecular mechanisms of caspase regulation during apoptosis Nat. Rev. Mol. Cell. Biol. 5 2004 897 907
2. E. Solary, B. Eymin, N. Droin, and M. Haugg Proteases, proteolysis, and apoptosis Cell Biol. Toxicol. 14 1998 121 132
3. Y. Gu, J. Wu, C. Faucheu, J.L. Lalanne, A. Diu, D.J. Livingston, and M.S. Su Interleukin-1 beta converting enzyme requires oligomerization for activity of processed forms in vivo EMBO J. 14 1995 1923 1931
4. K.P. Wilson, J.A. Black, J.A. Thomson, E.E. Kim, J.P. Griffith, M.A. Navia, M.A. Murcko, S.P. Chambers, R.A. Aldape, and S.A. Raybuck Structure and mechanism of interleukin-1 beta converting enzyme Nature 370 1994 270 275
5. K.M. Boatright, and G.S. Salvesen Mechanisms of caspase activation Curr. Opin. Cell Biol. 15 2003 725 731
6. K.M. Boatright, and G.S. Salvesen Caspase activation Biochem. Soc. Symp. 2003 233 242
7. K.M. Boatright, M. Renatus, F.L. Scott, S. Sperandio, H. Shin, I.M. Pedersen, J.E. Ricci, W.A. Edris, D.P. Sutherlin, D.R. Green, and G.S. Salvesen A unified model for apical caspase activation Mol. Cell 11 2003 529 541
8. Y. Shi Caspase activation: Revisiting the induced proximity model Cell 117 2004 855 858
9. C.S. Nobel, M. Kimland, D.W. Nicholson, S. Orrenius, and A.F. Slater Disulfiram is a potent inhibitor of proteases of the caspase family Chem. Res. Toxicol. 10 1997 1319 1324
10. N.A. Thornberry Interleukin-1 beta converting enzyme Methods Enzymol. 244 1994 615 631
11. L.C. Dang, R.V. Talanian, D. Banach, M.C. Hackett, J.L. Gilmore, S.J. Hays, J.A. Mankovich, and K.D. Brady Preparation of an autolysis-resistant interleukin-1 beta converting enzyme mutant Biochemistry 35 1996 14910 14916
12. H.R. Stennicke, and G.S. Salvesen Caspases: Preparation and characterization Methods 17 1999 313 319
13. J. Chai, Q. Wu, E. Shiozaki, S.M. Srinivasula, E.S. Alnemri, and Y. Shi Crystal structure of a procaspase-7 zymogen: Mechanisms of activation and substrate binding Cell 107 2001 399 407
14. P. Ramage, D. Cheneval, M. Chvei, P. Graff, R. Hemmig, R. Heng, H.P. Kocher, A. Mackenzie, K. Memmert, and L. Revesz Expression, refolding, and autocatalytic proteolytic processing of the interleukin-1 beta-converting enzyme precursor J. Biol. Chem. 270 1995 9378 9383
15. M.J. Romanowski, J.M. Scheer, T. O'Brien, and R.S. McDowell Crystal structures of a ligand-free and malonate-bound human caspase-1: Implications for the mechanism of substrate binding Structure (Camb.) 12 2004 1361 1371
16. C.Z. Ni, C. Li, J.C. Wu, A.P. Spada, and K.R. Ely Conformational restrictions in the active site of unliganded human caspase-3 J. Mol. Recognit. 16 2003 121 124
17. O.A. Andreassen, R.J. Ferrante, D.B. Hughes, P. Klivenyi, A. Dedeoglu, V.O. Ona, R.M. Friedlander, and M.F. Beal Malonate and 3-nitropropionic acid neurotoxicity are reduced in transgenic mice expressing a caspase-1 dominant-negative mutant J. Neurochem. 75 2000 847 852
18. J.B. Schulz, M. Weller, R.T. Matthews, M.T. Heneka, P. Groscurth, J.C. Martinou, J. Lommatzsch, R. von Coelln, U. Wullner, P.A. Loschmann, M.F. Beal, J. Dichgans, and T. Klockgether Extended therapeutic window for caspase inhibition and synergy with MK-801 in the treatment of cerebral histotoxic hypoxia Cell Death Differ. 5 1998 847 857
19. A. Paucard, B. Palmier, N. Croci, F. Taillieu, M. Plotkine, and I. Margaill Biphasic modulation by nitric oxide of caspase activation due to malonate injection in rat striatum Eur. J. Pharmacol. 483 2004 259 265
20. S. Toulmond, K. Tang, Y. Bureau, H. Ashdown, S. Degen, R. O'Donnell, J. Tam, Y. Han, J. Colucci, A. Giroux, Y. Zhu, M. Boucher, B. Pikounis, S. Xanthoudakis, S. Roy, M. Rigby, R. Zamboni, G.S. Robertson, G.Y. Ng, D.W. Nicholson, and J.P. Fluckiger Neuroprotective effects of M826, a reversible caspase-3 inhibitor, in the rat malonate model of Huntington's disease Br. J. Pharmacol. 141 2004 689 697
21. B.L. de Groot, D.M. van Aalten, R.M. Scheek, A. Amadei, G. Vriend, and H.J. Berendsen Prediction of protein conformational freedom from distance constraints Proteins 29 1997 240 251
22. A. Schweizer, C. Briand, and M.G. Grutter Crystal structure of caspase-2, apical initiator of the intrinsic apoptotic pathway J. Biol. Chem. 278 2003 42441 42447
23. D.A. Erlanson, J.W. Lam, C. Wiesmann, T.N. Luong, R.L. Simmons, W.L. DeLano, I.C. Choong, M.T. Burdett, W.M. Flanagan, D. Lee, E.M. Gordon, and T. O'Brien In situ assembly of enzyme inhibitors using extended tethering Nat. Biotechnol. 21 2003 308 314
24. Y. Wei, T. Fox, S.P. Chambers, J. Sintchak, J.T. Coll, J.M. Golec, L. Swenson, K.P. Wilson, and P.S. Charifson The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivity Chem. Biol. 7 2000 423 432
25. W. Watt, K.A. Koeplinger, A.M. Mildner, R.L. Heinrikson, A.G. Tomasselli, and K.D. Watenpaugh The atomic-resolution structure of human caspase-8, a key activator of apoptosis Struct. Fold. Des. 7 1999 1135 1143
26. M. Renatus, H.R. Stennicke, F.L. Scott, R.C. Liddington, and G.S. Salvesen Dimer formation drives the activation of the cell death protease caspase 9 Proc. Natl. Acad. Sci. USA 98 2001 14250 14255